Skip to main content

8-K

Abacus Global Management, Inc. (ABX)

8-K 2023-08-14 For: 2023-08-14
View Original
Added on April 07, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or Section 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 14, 2023

Abacus Life, Inc.

(Exact name of registrant as specified in its charter)

Delaware 001-39403 85-1210472
(State or other jurisdiction<br> <br>of incorporation or organization) (Commission<br> <br>File Number) (I.R.S. Employer<br> <br>Identification Number)

2101 Park Center Drive, Suite 170

Orlando, Florida 32835

(800) 561-4148

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
--- ---
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
--- ---
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
--- ---

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading<br> <br>Symbols Name of each exchange<br> <br>on which registered
Common stock, par value $0.0001 per share ABL The NASDAQ Stock Market LLC
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share ABLLW The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company  ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☒

Item 2.02. Results of Operations and Financial Condition

On August 14, 2023, Abacus Life, Inc. announced the results of its operations and its financial condition for the quarter ended June 30, 2023. The full text of the earnings release is included here as Exhibit 99.1 hereto.

Item 9.01. Financial Statement and Exhibits.
(a) Exhibits.
--- ---

99.1 Earnings Release dated August 14, 2023

104 Cover page Interactive Date file (embedded within Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

Abacus Life, Inc.
Date: August 14, 2023 By: /s/ Jay Jackson
Name: Jay Jackson
Title: Chief Executive Officer

2

EX-99.1

Exhibit 99.1

ABACUS LIFE REPORTS SECOND QUARTER 2023 RESULTS

- Revenue Grew 30% Year-over-Year to $18.3 Million -

- Increased Originations Capital Deployment by 88% Year-over-Year to $59.7 Million -

- Net Income Increased 40% Year-over-Year to $6.4 Million -

- Adjusted EBITDA Grew 33% Year-over-Year to $8.8 Million -

ORLANDO, Fla. – August 14, 2023 – Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, today reported results for the second quarter ended June 30, 2023.

“Our strong second quarter results continue to validate Abacus’ differentiated business model and further contribute to our long track record of sustainable and profitable growth,” said Jay Jackson, Chief Executive Officer of Abacus Life. “In addition to our continued progress, we were very pleased to successfully complete our public listing post-quarter end, a milestone for our long-term growth ambitions. Our proven business model, expert team, and our wealth of data and innovative technology positions us well to execute on our strategic initiatives, take advantage of the many exciting opportunities that lie ahead, and ultimately create long-term value for our shareholders.”

Second Quarter 2023 Highlights

Total revenue grew 30% to $18.3 million, compared to $14.1 million in the prior-year period<br>
Originations capital deployment increased 88% to $59.7 million, compared to $31.9 million in the<br>prior-year period; number of policy originations grew 4% to 141, compared to 135 in the prior-year period
--- ---
Total operating expenses (excluding unrealized gains and losses and change in fair value) were $4.3 million,<br>compared to $4.6 million in the prior-year period
--- ---
Net income increased 40% to $6.4 million, compared to $4.6 million in the prior-year period<br>
--- ---
Adjusted EBITDA grew 33% to $8.8 million, compared to $6.6 million in the prior-year period<br>
--- ---
Adjusted EBITDA margin of 48.4%, compared to 47.0% in the prior-year period
--- ---
Annualized Return on invested capital (ROIC) for the quarter ended June 30, 2023 of 28.5%<br>
--- ---
Annualized Return on equity (ROE) for the quarter ended June 30, 2023 of 16.0%
--- ---

Second Quarter 2023 Results

Active management revenue increased 38% to $11.0 million, compared to $8.0 million in the prior-year<br>period. The increase was primarily attributable to maturities of policies accounted for under the investment method.
Total revenue from portfolio servicing segment was $0.4 million, roughly comparable to the prior-year<br>period.
--- ---
Originations revenue at Abacus Settlements nearly quadrupled to $2.7 million, compared to $0.7 million<br>in the prior-year period. The increase was primarily attributable to higher pricing on the sale of broker policies which led to higher commission fees.
--- ---
Related party revenue at Abacus Settlements was $4.1 million, compared to $4.9 million in the<br>prior-year period. The decrease was mainly due to a decrease in Nova Origination sales and transaction fee reimbursements, partially offset by increased LMA Originations services.
--- ---
Net income increased 40% to $6.4 million, compared to $4.6 million in the prior-year period, driven by<br>strong top-line performance and managing costs efficiently.
--- ---
Adjusted EBITDA for the quarter grew 33% to $8.8 million, compared to $6.6 million in the prior-year<br>period. The increase was primarily attributable to strong revenue growth, partially offset by higher operating expenses. Adjusted EBITDA margin remained strong at 48.4% for the quarter, compared to 47.0% in the prior-year period.<br>
--- ---

Liquidity and Capital

As of June 30, 2023, the Company had cash and cash equivalents of $20.6 million, balance sheet policy assets of $66.5 million **** and outstanding long-term debt at fair value of $66.2 million.

Webcast and Conference Call

A webcast and conference call to discuss the Company’s results will be held today beginning at 9:00 a.m. (Eastern Time). A live webcast of the conference call will be available on Abacus Life’s investor relations website at ir.abacuslifesettlements.com. The dial-in number for the conference call is (877) 407-9716 (toll-free) or (201) 493-6779 (international). Please dial the number 10 minutes prior to the scheduled start time.

A webcast replay of the call will be available at ir.abacuslifesettlements.com for one year following the call.

Safe Harbor Statement

Statements made in this press release that are not historical facts, including statements accompanied by words such as “will,” “believe,” “estimate,” “expect,” “intend,” “anticipate,” “goals,” “prospects,” or similar words, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding the Company’s plans and performance. These statements are based on management’s estimates, assumptions and projections as of the date of this release and are not guarantees of future performance. Actual results may differ materially from the results expressed or implied in these statements as the result of risks, uncertainties and other factors including, but not limited to: the fact that our loss reserves are bases on estimates and may be inadequate to cover our actual losses; the failure to properly price our insurance policies; the geographic concentration of our business; the cyclical nature of our industry; the impact of regulation on our business; the effects of competition; failing to sustain our relationships with independent agencies; the failure to meet our investment objectives; the inability to acquire additional capital on favorable terms; the effects of acts of terrorism and the factors set forth in the Company’s filings with the Securities and Exchange Commission (the “SEC”), including the Annual Report on Form 10-K and Quarterly Report on Form 10-Q and subsequent periodic reports. The Company cautions you not to place undue reliance on the forward-looking statements contained in this release. Any forward –looking statements speak only as of their dates. The Company does not undertake any obligation to publicly update or revise any forward-looking statements to reflect future events, information or circumstances that arise after the date of this release.

About Abacus

Abacus is a leading vertically integrated alternative asset manager specializing in life insurance products. Since 2004, the Company has purchased life insurance policies from consumers seeking liquidity and has actively managed those policies over time (via trading, holding, and/or servicing). With over $2.9 billion in face value of policies purchased, Abacus has helped thousands of clients maximize the value of their life insurance.

Over the past 19 years, the Company has built an institutionalized origination and portfolio management process that is supported by an 84-person team, long-term relationships with 78 institutional partners and 30,000 financial advisors, and the ability to operate in 49 states. The Company has serviced approximately $950 million in policies and has managed assets for large asset managers and third-party investment funds.

Abacus’ leadership team averages 20+ years of experience and consists of innovators since the life settlements industry’s inception in the mid-90s.

The Company is a proud member of the Life Insurance Settlements Association (LISA) and complies with HIPAA and privacy laws to maintain and protect confidentiality of financial, health, and medical information. Abacus is also proud to be a BBB Accredited Business with an A+ rating.

www.Abacuslife.com

Contact:

Abacus Life Investor Relations

investors@abacuslife.com

Abacus Life Public Relations

press@abacuslife.com

ABACUS LIFE, INC.

Condensed Consolidated Balance Sheets

June 30,<br>2023(unaudited) December 31,2022
ASSETS
CURRENT ASSETS:
Cash and cash equivalents $ 20,611,122 $ 30,052,823
Accounts receivable 192,595 10,448
Related party receivable 78,310 198,364
Due from affiliates 10,473,748 2,904,646
Other receivables 21,252
Prepaid expenses and other current assets 829,595 116,646
Total current assets 32,206,622 33,282,927
Property and equipment, net 177,931 18,617
Intangible assets, net 32,900,000
Goodwill 140,287,000
Operating<br>right-of-use assets 240,816 77,011
Life settlement policies, at cost 9,889,610 8,716,111
Life settlement policies, at fair value 56,685,617 13,809,352
Available for sale securities, at fair value 1,000,000 1,000,000
Other investments 1,600,000 1,300,000
Due from members and affiliates 75,582
State security deposit 206,873
Certificate of deposit 262,500
Other assets, at fair value 1,801,886 890,829
TOTAL ASSETS $ 277,334,437 $ 59,094,847
LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)
CURRENT LIABILITIES:
Accrued expenses $ 524,400 $
Accounts payable 401,500 40,014
Operating lease liabilities - current portion 227,561 48,127
Due to members and affiliates 10,415,154 263,785
Due to owners 717,429
Contract liabilities - deposits on pending settlements 981,217
Accrued transaction costs 182,571 908,256
Other current liabilities 258,759 42,227
Income taxes payable 185,831
Total current liabilities 13,894,422 1,302,409

Abacus Life, Inc.

Condensed Consolidated Balance Sheets

SPV purchase and sale note 25,000,000
Long-term debt, at fair value 66,165,396 28,249,653
Operating lease liabilities - noncurrent portion 16,864 29,268
Deferred tax liability 9,320,240 1,363,820
Warrant liability 2,438,600
TOTAL LIABILITIES 116,835,522 30,945,150
COMMITMENTS AND CONTINGENCIES (11)
SHAREHOLDERS’ EQUITY (DEFICIT)
Class A common stock, 0.0001 par value; 200,000,000 authorized shares; 62,961,688 shares<br>issued and outstanding 6,296
LMA members’ capital 50,000
Additional paid-in capital 188,641,886 660,000
Retained earnings/(accumulated deficit) (29,382,362 ) 25,487,323
Accumulated other comprehensive income 877,306 1,052,836
Non-controlling interest 355,789 899,538
Total shareholders’ equity (deficit) 160,498,915 28,149,697
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT) 277,334,437 $ 59,094,847

All values are in US Dollars.

The accompanying notes are an integral part of these interim condensed consolidated financial statements.

Abacus Life, Inc.

Condensed Consolidated Statement of Operations

Three Months Ended<br>June 30,
2023 2022
REVENUES:
Portfolio servicing revenue
Related party servicing revenue $ 329,629 $ 419,253
Portfolio Servicing revenue 24,737 169
Total portfolio servicing revenue<br><br><br>Active management revenue 354,366 419,422
Investment Income from life insurance policies held using investment method 8,263,499 5,965,466
Change in fair value of life insurance policies (policies held using fair value method) 2,760,900 2,014,013
Total active management revenue 11,024,399 7,979,479
Total revenues 11,378,765 8,398,901
COST OF REVENUES (Excluding depreciation stated below)
Cost of revenue 973,400 666,119
Total cost of revenue 973,400 666,119
Gross Profit 10,405,365 7,732,782
OPERATING EXPENSES:
Sales and marketing 683,841 1,019,498
General and administrative expenses 577,539 5,499
Loss on change in fair value of debt 1,445,229 333,879
Unrealized loss (gain) on investments (672,936 ) 1,039,022
Depreciation 1,098 1,098
Total operating expenses 2,034,771 2,398,996
Operating Income $ 8,370,594 $ 5,333,786
OTHER INCOME (EXPENSE)
Interest (expense) (584,075 )
Interest income
Other income (expense) 121,601 (127,455 )
Total other income (expense) (462,474 ) (127,455 )
Net income before provision for income taxes 7,908,120 5,206,331
(Provision for)/Benefit from income taxes (1,184,571 ) (120,132 )
NET INCOME 6,723,549 5,086,199
LESS: NET INCOME (LOSS) ATTRIBUTABLE TO NONCONTROLLING INTEREST (26,596 ) 406,641
NET INCOME ATTRIBUTABLE TO SHAREHOLDERS 6,750,145 4,679,558

ABACUS SETTLEMENTS, LLC

Condensed Consolidated Statement to Operations

Three Months Ended<br><br><br>June 30
2023 2022
Origination revenue $ 2,745,339 $ 743,388
Related party revenue 4,139,351 4,948,528
Total revenue 6,884,690 5,691,916
Cost of revenue 2,407,021 956,625
Related party cost of revenue 2,490,959 2,615,307
Total cost of revenue 4,897,980 3,571,932
Gross Profit 1,986,710 2,119,984
OPERATING EXPENSES:
General and administrative expenses 2,297,577 2,208,051
Depreciation 2,561 3,048
Total operating expenses 2,300,138 2,211,099
Income (Loss) from operations (313,428 ) (91,115 )
OTHER INCOME (EXPENSE)
Interest income 1,193 599
Interest (expense) (5,863 )
Other income 273
Total other income (expense) (4,670 ) 872
Income (Loss) before income taxes (318,098 ) (90,243 )
Provision for income taxes
NET INCOME (LOSS) AND COMPREHENSIVE $ (318,098 ) $ (90,243 )
WEIGHTED-AVERAGE UNITS USED IN COMPUTING NET INCOME (LOSS) PER UNIT:
Basic $ 400 400
Diluted $ 400 400
NET INCOME/(LOSS) PER UNIT:
Basic earnings per unit $ (795.25 ) $ (225.61 )
Diluted earnings per unit $ (795.25 ) $ (225.61 )

See accompanying notes to interim condensed consolidated financial statement

PROFORMA COMBINED (ABACUS LIFE, INC. AND ABACUS SETTLEMENTS, LLC)

Condensed Consolidated Statement of Operations

Q2 2023 Q2 2022 Increase % Increase
Revenue
Origination Revenue 6,884,690 5,691,916 1,192,774 21 %
Portfolio & Servicing Revenue 354,366 419,422 (65,056 ) (16 %)
Active Management Revenue 11,024,399 7,979,479 3,044,920 38 %
Total Revenue 18,263,455 14,090,817 4,172,638 30 %
Cost of Revenue
Origination Cost of Revenue 4,897,980 3,571,932 1,326,048 37 %
Portfolio & Servicing Cost of Revenue 973,400 666,119 307,281 46 %
Total Cost of Revenue 5,871,380 4,238,051 1,633,329 39 %
Gross Profit 12,392,075 9,852,766 2,539,309 26 %
Expenses
Operating Expenses (Abacus & LMA) 4,334,909 4,610,095 (275,186 ) (6 %)
Other (Income)/Expense 467,144 126,583 340,561 269 %
Income Tax Provision / (Benefit) 1,184,571 120,132 1,064,439 886 %
Non-Controlling Interest Income / (Loss) (26,596 ) 406,641 (433,237 ) (107 %)
Net Income 6,432,047 4,589,315 1,842,732 40 %
EBITDA 8,833,118 6,619,991 2,213,127 33 %
Capital Deployed through Abacus 59,764,389 31,809,025 27,955,364 88 %
3rd Party Capital Deployed through LMA 20,638,467 46,274,631 (25,636,164 ) (55 %)
Total Capital Deployed 80,402,856 78,083,657 2,319,199 3 %